American Drug Utilization Review Society (ADURS)
ADURS was organized in 1990 and existed until 2000 as a funded group within Searle Inc. ADURS was incorporated as a non-profit 501.c.6 corporation in 2001 when Searle merged with Upjohn to form Pharmacia. At that time Pharmacia made a decision that ADURS should be a private organization supported by a “Select” group of pharmaceutical industry co-sponsors.
The group membership is individuals active in drug utilization review (DUR) of the 50 State and District of Columbia Medicaid programs. The mission of ADURS is to provide a forum of leadership and support for the membership to obtain information, develop skills and receive training to efficiently and effectively perform their duties. The focus of its member’s duties is the achievement of optimum health care outcomes.
The annual symposium is the main educational event of ADURS. Symposiums are funded by registration fees. The symposium is held the latter part of February or early March and attendees are on a limited basis. Only a set number of corporate attendees and individuals directly involved with a State Medicaid DUR initiative and/or program may attend each year. The symposium averages around 120 individuals representing an average of 43 State Medicaid programs. Approximately 12.50 to 13.50 hours of ACPE approved continuing education credits has been provided for each symposium.
The staff consists of a 0.20 FTE administrative assistant. The Executive Director and Directors are volunteers.
The mission of ADURS is to provide a forum of leadership and support for the membership to obtain information, develop skills, and receive training to efficiently and effectively perform their duties.